会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • Ureylene phenylene anionic naphthalene-sulfonic acids, their use as complement system inhibitors in a body fluid and process for their preparation
    • 阴离子Ureylenphenylen萘酸,它们作为Komplementsystemhemmer体液和它们的制备方法使用。
    • EP0008154A1
    • 1980-02-20
    • EP79301036.4
    • 1979-06-01
    • AMERICAN CYANAMID COMPANY
    • Siuta, Gerald JosephPoletto, John FrankConrow, Ransom BrownBernstein, Seymour
    • C07C143/675C07C143/80A61K31/18A61K31/185
    • C07C309/59A61K31/185C07C309/47C07C311/46C07C311/47
    • The present invention provides novel ureylene phenylene anionic naphthalenesulfonic acids, which have complement-inhibiting properties and which may be represented by the general formula:
      wherein X and Y are each selected from the group consisting of -CO- and -SO 2 -; R and R 3 are each selected from the group consisting of hydrogen, methyl and -S0 3 A, wherein A is a pharmaceutically acceptable salt cation; R, and R 4 are each selected from the group consisting of hydrogen and -COOB. wherein B is selected from the group consisting of hydrogen and a pharmaceutically acceptable salt cation; R 2 and R s are each selected from the group consisting of hydrogen and methyl; with the proviso that R. R,, R 2 , R 3 , R 4 and R 5 may not all be hydrogen; with the second proviso that when X and Y are both -CO- and R 2 is methyl, then R, R,, R 3 , R. and R s may not all be hydrogen; and with the third proviso that no phenyl moiety can contain both -SO 3 A and -COOB.
      The corresponding amine compounds of the formula below are novel intermediates for the novelureylene compounds above:
    • 本发明提供了新颖的亚脲基苯基阴离子萘磺酸,具有补体抑制特性-并且其可以是由以下通式表示:各自选自-CO-和-SO 2 - 中选出worin X和Y; 被选自氢,甲基和-SO3A各自选择的R和R3,worin A是药学上可接受的盐的阳离子; R1和R4各自选自氢和-COOB的选择,worin B被选自氢和药学上可接受的盐的阳离子的选择; R1和R5各自选自氢和甲基中选择; 其条件没有R,R1,R2,R3,R4和R5可以不全部是氢; 与所述第二条件做了当X和Y均为-CO-且R 2为甲基时,则R,R1,R3,R4和R5可以不全部是氢; 和与第三条件确实没有苯基部分可以同时包含-SO3A和-COOB。 下式的相应的胺化合物可用于上述novelureylene化合物的新的中间体:ð